<?xml version="1.0" encoding="UTF-8"?>
<p>Previous pharmacological studies with crude extracts of 
 <italic>C. articulatus</italic> and its components have reported this plant as a source of anticonvulsant [
 <xref rid="B13-molecules-25-02687" ref-type="bibr">13</xref>], sedative [
 <xref rid="B14-molecules-25-02687" ref-type="bibr">14</xref>], antifungal [
 <xref rid="B15-molecules-25-02687" ref-type="bibr">15</xref>], anti-plasmodial [
 <xref rid="B16-molecules-25-02687" ref-type="bibr">16</xref>], anti-
 <italic>Onchocerca</italic> [
 <xref rid="B17-molecules-25-02687" ref-type="bibr">17</xref>], antibacterial [
 <xref rid="B18-molecules-25-02687" ref-type="bibr">18</xref>], antioxidant [
 <xref rid="B19-molecules-25-02687" ref-type="bibr">19</xref>] and cytotoxic [
 <xref rid="B19-molecules-25-02687" ref-type="bibr">19</xref>] agents. Regarding its cytotoxic properties, Kavaz et al. [
 <xref rid="B19-molecules-25-02687" ref-type="bibr">19</xref>] published a preliminary study showing that 
 <italic>C. articulatus</italic> rhizome essential oil (EO), collected in northern Nigeria, exhibited cytotoxicity against human breast adenocarcinoma MDA-MB-231 cells, and its chemical composition included sesquiterpenes, monoterpenes, nootkatone, 6-methyl-3,5-heptadien-2-one, retinene, nopinone, cycloeucalenol, anozol, toosendanin, furanone, ethanone and vitamin A [
 <xref rid="B19-molecules-25-02687" ref-type="bibr">19</xref>]. Here, the 
 <italic>C. articulatus</italic> rhizome EO, collected in the Brazilian Amazon rainforest, was studied for its chemical composition, induction of cell death in vitro and the inhibition of tumor development in vivo using human hepatocellular carcinoma HepG2 cells as a cell model.
</p>
